Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD
Viera Kupčová, Michaela Fedelešová, J Bulas, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 19, pp. 3570-3570
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 191
Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
Pau Vancells Lujan, Esther Viñas Esmel, Emilio Sacanella
Nutrients (2021) Vol. 13, Iss. 5, pp. 1442-1442
Open Access | Times Cited: 138
NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2841-2841
Open Access | Times Cited: 95
Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis
Hongwei Chen, Jue Wang, Zheng Li, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 12, pp. 2192-2192
Open Access | Times Cited: 88
The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases
Kamila Wójcik, Ewa Koślińska-Berkan, Anna Piekarska
Clinical and Experimental Hepatology (2018) Vol. 4, Iss. 1, pp. 1-6
Open Access | Times Cited: 66
The non-invasive assessment of hepatic fibrosis
Gina Gheorghe, Simona Bungău, Gabriela Ceobanu, et al.
Journal of the Formosan Medical Association (2020) Vol. 120, Iss. 2, pp. 794-803
Open Access | Times Cited: 56
MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 29
The great potential of flavonoids as candidate drugs for NAFLD
Liangge Li, Yiming Qin, Xijian Xin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114991-114991
Open Access | Times Cited: 17
The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis
Ehsan Amini‐Salehi, Soheil Hassanipour, Mohammad‐Hossein Keivanlou, et al.
Nutrition Reviews (2023) Vol. 82, Iss. 6, pp. 815-830
Closed Access | Times Cited: 17
Natural compounds proposed for the management of non-alcoholic fatty liver disease
Théodora Merenda, Florian Juszczak, Elisabeth Ferier, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases
Eliane Münte, Phillipp Hartmann
Biomolecules (2025) Vol. 15, Iss. 4, pp. 469-469
Open Access
Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study
Josep Franch‐Nadal, Llorenç Caballería, Manel Mata‐Cases, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0198327-e0198327
Open Access | Times Cited: 42
Production of Elastin-Derived Peptides Contributes to the Development of Nonalcoholic Steatohepatitis
Béatrice Romier, Corinne Ivaldi, Hervé Sartelet, et al.
Diabetes (2018) Vol. 67, Iss. 8, pp. 1604-1615
Open Access | Times Cited: 41
Old age as a risk factor for liver diseases: Modern therapeutic approaches
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva
Experimental Gerontology (2023) Vol. 184, pp. 112334-112334
Open Access | Times Cited: 11
Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms - a network pharmacology and experimental investigation
Jing He, Yi-cai Qian, Ying-chuan Yin, et al.
Chemico-Biological Interactions (2024) Vol. 398, pp. 111110-111110
Closed Access | Times Cited: 3
SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women
Jinchunzi Yang, Elisa Félix‐Soriano, Alejandro Martínez-Gayo, et al.
Journal of Physiology and Biochemistry (2024)
Open Access | Times Cited: 3
Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease
Eleni Asprouli, Ioanna Panagiota Kalafati, Aikaterini Sakellari, et al.
Biological Trace Element Research (2018) Vol. 188, Iss. 2, pp. 326-333
Closed Access | Times Cited: 37
Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology
Wenjun Zhou, Ziye Zhu, Xiaoli Xiao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112181-112181
Open Access | Times Cited: 24
Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting
Kim Huard, Aaron Smith, Gregg D. Cappon, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 19, pp. 10879-10896
Closed Access | Times Cited: 24
Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
Kwang Min Kim, Ji-Hye Roh, Sangjin Lee, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics
Svenja Sydor, Christian Dandyk, Johannes Schwerdt, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8841-8841
Open Access | Times Cited: 12
Efficacy of the Mediterranean Diet Containing Different Macronutrients on Non-Alcoholic Fatty Liver Disease
Vahibe Uluçay Kestane, Murat Baş
Nutrients (2024) Vol. 16, Iss. 16, pp. 2699-2699
Open Access | Times Cited: 2
Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease
Shendong Wang, Junhao Yin, Zhaojun Liu, et al.
Life Sciences (2024) Vol. 359, pp. 123211-123211
Closed Access | Times Cited: 2
Metabolic Syndrome-Related Features in Controlled and Resistant Hypertensive Subjects
Arthur Santa Catharina, Rodrigo Modolo, Alessandra Mileni Versuti Ritter, et al.
Arquivos Brasileiros de Cardiologia (2018)
Open Access | Times Cited: 21
Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population
Xinting Pan, Xiaoxu Xie, Hewei Peng, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top